Effect of Long-term Administration of Oral Magnesium Sulfate and Insulin to Reduce Streptozotocin-Induced Hyperglycemia in Rats: the Role of Akt2 and IRS1 Gene Expressions
The effects of long-term oral administration of magnesium sulfate and insulin on hyperglycemia were investigated using Akt2 and IRS1 gene expression methods in streptozotocin-induced diabetic rats. Fifty rats were randomly divided into five experimental groups: 1, non-diabetic control (NDC); 2, Mg2+-treated non-diabetic control (Mg-NDC); 3, chronic diabetic (CD); 4, Mg2+-treated chronic diabetic (Mg-CD); and 5, insulin-treated chronic diabetic (Ins-CD). Streptozotocin was used to induce diabetes. The Mg-CD and Mg-NDC groups received 10 g/l of MgSO4 added to drinking water. The Ins-CD group received 2.5 U/kg of insulin twice a day. Blood glucose level and body weight were measured every week. The intraperitoneal glucose tolerance test (IPGTT) was performed after 16 weeks. MgSO4 administration improved the blood glucose level and IPGTT. It also increased Akt2 and IRS1 genes as well as protein expression. Insulin lowered the blood glucose level and increased IRS1 gene and protein expression, but did not affect Akt2 gene and protein expression. Glucose reduction after Mg therapy may be mediated, at least partially, via IRS1 and Akt2 genes and protein stimulation. In insulin-treated rats, insulin resistance was not significant due to the absence of Akt2 gene expression.
KeywordsDiabetes Magnesium Insulin Akt2 IRS1
This study was supported by the Hormozgan University of Medical Science under grant number 9471.
Compliance with Ethical Standards
The animals were managed in agreement with the criteria defined in the NIH publication no. 85-23, revised in 1985, and the experimental protocol was approved by the Ethics Committee HUMS REC.1394.112 for Animal Care of Hormozgan University of Medical Sciences.
- 12.Balkwill FR (2000) The cytokine network: frontiers in molecular biology. Oxford University Press, LondonGoogle Scholar
- 18.Olfert E, Cross B, McWilliam A (1993) Canadian Council on Animal Care—guide to the care and use of experimental animals, vol. 1. Brada Printing Services, Ottawa, ONGoogle Scholar
- 19.Sohrabipour S, Sharifi MR, Sharifi M, Talebi A, Soltani N (2018) Effect of magnesium sulfate administration to improve insulin resistance in type 2 diabetes animal model: using the hyperinsulinemic-euglycemic clamp technique. Fundam Clin Pharmacol 32(6):603–616Google Scholar
- 26.Suarez A, Pulido N, Casla A, Casanova B, Arrieta F, Romero R, Rovira A (1993) Decreased insulin sensitivity in skeletal muscle of hypomagnesemic rats. Springer Verlag, NEW YORK, NY 10010, pp A123–A123Google Scholar
- 27.Chutia H, Lynrah KG (2015) Association of serum magnesium deficiency with insulin resistance in type 2 diabetes mellitus. J Lab Phys 7(2):75–78Google Scholar
- 29.Gandhi GR, Jothi G, Antony PJ, Balakrishna K, Paulraj MG, Ignacimuthu S, Stalin A, Al-Dhabi NA (2014) Gallic acid attenuates high-fat diet fed-streptozotocin-induced insulin resistance via partial agonism of PPARγ in experimental type 2 diabetic rats and enhances glucose uptake through translocation and activation of GLUT4 in PI3K/p-Akt signaling pathway. Eur J Pharmacol 745:201–216CrossRefPubMedCentralGoogle Scholar